Local Institution - 0167

Seoul 120-752

1 studies enrolling now · 2 studies all time

What they study most

Advanced Renal Cell Carcinoma (RCC), Hepatocellular Carcinoma, Liver Cancer

Studies at this site

• A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) — Recruiting now
• A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation — Running, not enrolling